Answer
Etravirine is not recommended in patients with severe hepatic impairment (Child-Pugh Class C) because it has not been studied in this group.
Sources for this answer
- Intelence 100 mg tablets (Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.4 Special warnings and precautions for use · Version 26Document updated
Sources checked